Wolfgang Miesbach: Base Editing Expands Therapeutic Targets for Hemophilia B
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:
“Base editing for haemophilia B at ISTH 2026.
Tsukasa Ohmori (Jichi Medical University) presented OC 58.3, with Satoshi Omura, Hiroshi Nishimasu and Osamu Nureki (University of Tokyo).
The rationale Haemophilia B is mostly caused by single-nucleotide variants in F9. Base editing rewrites the base without a double-strand break, resulting in less genome toxicity.
In the EAHAD database: 4,151 of 4,657 F9 variants (89.1%) are point mutations, and 67.2% are in principle base-editor-correctable.
The obstacle: The PAM (protospacer adjacent motif) is a short DNA motif next to the target that Cas9 must recognise before it can bind. It fixes the editing window – and decides which variants are reachable at all. SaCas9 fits into AAV (1,053 aa, 3.2 kb) but demands NNGRRT, which excludes most variants.
The advance Structure-guided engineering resulted in SaCas9-NNG, requiring only a single G.
Results
- Efficient hepatic cleavage at NNGA, NNGT, NNGC sites – not achieved by wild-type SaCas9
- Adenine base editor with sgRNA in a single AAV8 vector, liver-specific promoter
- F9 c.280G>A: corrected in approximately 60% of hepatocytes, significant rise in FIX activity (wild type: 0%)
- F9 c.364G>A: approximately 40%, higher than wild type but not significant
- Non-viral arm: ABE8e-SpRY by lipid nanoparticle restored 52–70% FIX activity across three patient variants (Hiya-Kawaguchi et al., JTH, in press)
PAM compatibility decides how many patients a base editor can serve. A previously untargetable variant corrected in most hepatocytes, from one vector, is a real step forward.”
Other posts featuring Wolfgang Miesbach on Hemostasis Today.
-
Aug 6, 2026, 18:11Filipe Gonçalves: Are DOACs Truly Pharmacokinetically Predictable or Simply Pharmacodynamically Forgiving?
-
Aug 6, 2026, 18:03Identifing Gaps in How IDA is Recognised and Managed in Children – ISBT
-
Aug 6, 2026, 18:03Expanding Access to Care for People With Hemophilia in Côte d’Ivoire – WFH
-
Aug 6, 2026, 18:00Kavita Vinod Paul: Transforming Lives Through Comprehensive Care and Community Leadership
-
Aug 6, 2026, 17:59BSH Good Practice Paper on Multidisciplinary Hematology and Gynecology Care – British Journal of Haematology
-
Aug 6, 2026, 17:38Cameron Cook: How Cost-Effective Is Evolocumab for Patients at High Cardiovascular Risk?
-
Aug 6, 2026, 15:53Pall T. Onundarson: Frail Elderly Korean Atrial Fibrillation Patients Do Worse If Switched to DOACs in a Nationwide Observational Study
-
Aug 6, 2026, 15:46Zain Khalpey: Left Atrial Appendage Closure vs Oral Anticoagulation in Atrial Fibrillation
-
Aug 6, 2026, 15:25Mohd Ashhad: Cryoprecipitate – A Small Blood Component with a Big Clinical Role